Product
Supplier
Encyclopedia
Inquiry
Home > News > Market Flash > How pharmaceutical wholesalers can prevent compliance risks

How pharmaceutical wholesalers can prevent compliance risks

2021-07-07

Combing the provincial drug regulatory departments website publicized the revocation of the "Drug Certification of Quality Management Practice" announcement found that a significant number of drug wholesale enterprises due to illegal sales of drugs, to units or individuals who do not have legal qualifications to provide drugs and other illegal acts, the regulatory authorities identified as not operating in accordance with the law, thus being revoked certificate. The author believes that the root cause of the above problems lies in the failure of pharmaceutical wholesalers to seriously carry out compliance management and compliance risk prevention, that is, the failure to establish a compliance management system suitable for business operations.

Drug wholesale enterprises to establish compliance system, compliance management, to prevent possible compliance risks, first of all, to clarify the laws and regulations, standards, contracts and other provisions of the obligations to be performed by enterprises; in the process of drug sales, laws and regulations should be identified on the restrictive provisions of drug wholesale enterprises to sell drugs.

Disclaimer: ECHEMI reserves the right of final explanation and revision for all the information.
Comment
Comment

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.